An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of Colorectal Cancer

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2020 Dec 9

PMID 33294444

Citations 11

Authors

Meng-Lu Zeng

Xian-Jin Zhu

Jin Liu

Peng-Chong Shi

Yan-Li Kang

Zhen Lin

Ying-Ping Cao

Affiliations

Soon will be listed here.

Abstract

Background: S100 family genes exclusively encode at least 20 calcium-binding proteins, which possess a wide spectrum of intracellular and extracellular functions in vertebrates. Multiple lines of evidences suggest that dysregulated S100 proteins are associated with human malignancies including colorectal cancer (CRC). However, the diverse expression patterns and prognostic roles of distinct S100 genes in CRC have not been fully elucidated.

Methods: In the current study, we analyzed the mRNA expression levels of S100 family genes and proteins and their associations with the survival of CRC patients using the Oncomine analysis and GEPIA databases. Expressions and mutations of S100 family genes were analyzed using the cBioPortal, and protein-protein interaction (PPI) networks of S100 proteins and their mutation-related coexpressed genes were analyzed using STRING and Cytoscape.

Results: We observed that the mRNA expression levels of S100A2, S100A3, S100A9, S100A11, and S100P were higher and the level of S100B was lower in CRC tissues than those in normal colon mucosa. A high S100A10 levels was associated with advanced-stage CRC. Results from GEPIA database showed that highly expressed S100A1 was correlated with worse overall survival (OS) and disease-free survival (DFS) and that overexpressions of S100A2 and S100A11 were associated with poor DFS of CRC, indicating that S100A1, S100A2, and S100A11 are potential prognostic markers. Unexpectedly, most of S100 family genes showed no significant prognostic values in CRC.

Conclusions: Our findings, though still need to be ascertained, offer novel insights into the prognostic implications of the S100 family in CRC and will inspire more clinical trials to explore potential S100-targeted inhibitors for the treatment of CRC.

Citing Articles

An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.

Zhou X, Qian Y, Ling C, He Z, Shi P, Gao Y J Transl Med. 2024; 22(1):321.

PMID: 38555418 PMC: 10981831. DOI: 10.1186/s12967-024-05127-5.

The role of miR-6884-5p in epithelial-mesenchymal transition in non-small cell lung cancer.

Zhang L, Chi W, Wang X, Li J, Li F, Ma Y Aging (Albany NY). 2024; 16(2):1968-1979.

PMID: 38271114 PMC: 10866446. DOI: 10.18632/aging.205474.

Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer.

Sun J, Baker J, Russell C, Pham H, Goldsmith C, Cossar P RSC Med Chem. 2023; 14(11):2246-2267.

PMID: 37974967 PMC: 10650957. DOI: 10.1039/d2md00289b.

Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer.

Hatthakarnkul P, Ammar A, Pennel K, Officer-Jones L, Cusumano S, Quinn J J Cancer. 2023; 14(10):1837-1847.

PMID: 37476187 PMC: 10355195. DOI: 10.7150/jca.83910.

Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune cells in human pancreatic adenocarcinoma.

Ren Y, Chen B, Zhang M, Xu F Medicine (Baltimore). 2023; 102(8):e32976.

PMID: 36827067 PMC: 11309628. DOI: 10.1097/MD.0000000000032976.

References

Donato R . S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001; 33(7):637-68. DOI: 10.1016/s1357-2725(01)00046-2. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Kwon M, Yoon C, Jeong W, Rhee S, Waisman D . Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin. J Biol Chem. 2005; 280(25):23584-92. DOI: 10.1074/jbc.M504325200. View

Kang M, Lee H, Lee Y, Choi W, Park Y, Jeong C . S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells. Urology. 2014; 85(1):273.e9-15. DOI: 10.1016/j.urology.2014.09.018. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Huang M, Wang H, Tok T, Chang H, Chang M, Cheng T . EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patients. DNA Cell Biol. 2011; 31(4):625-35. DOI: 10.1089/dna.2011.1365. View

Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D . Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 2010; 5(10). PMC: 2948500. DOI: 10.1371/journal.pone.0013091. View

Kaiser S, Park Y, Franklin J, Halberg R, Yu M, Jessen W . Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007; 8(7):R131. PMC: 2323222. DOI: 10.1186/gb-2007-8-7-r131. View

Wright N, Cannon B, Zimmer D, Weber D . S100A1: Structure, Function, and Therapeutic Potential. Curr Chem Biol. 2009; 3(2):138-145. PMC: 2771873. DOI: 10.2174/187231309788166460. View

10.

Bronckart Y, Decaestecker C, Nagy N, Harper L, Schafer B, Salmon I . Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins. Histol Histopathol. 2001; 16(3):707-12. DOI: 10.14670/HH-16.707. View

11.

Wang G, Wang X, Wang S, Song H, Sun H, Yuan W . Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues. Int J Colorectal Dis. 2008; 23(7):675-82. DOI: 10.1007/s00384-008-0464-6. View

12.

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

13.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

14.

He H, Li J, Weng S, Li M, Yu Y . S100A11: diverse function and pathology corresponding to different target proteins. Cell Biochem Biophys. 2009; 55(3):117-26. DOI: 10.1007/s12013-009-9061-8. View

15.

Massi D, Landriscina M, Piscazzi A, Cosci E, Kirov A, Paglierani M . S100A13 is a new angiogenic marker in human melanoma. Mod Pathol. 2010; 23(6):804-13. PMC: 2882157. DOI: 10.1038/modpathol.2010.54. View

16.

Notterman D, Alon U, Sierk A, Levine A . Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001; 61(7):3124-30. View

17.

Giraldez M, Lozano J, Cuatrecasas M, Alonso-Espinaco V, Maurel J, Marmol M . Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy. Int J Cancer. 2012; 132(5):1090-7. DOI: 10.1002/ijc.27747. View

18.

Kwon M, Macleod T, Zhang Y, Waisman D . S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci. 2004; 10:300-25. DOI: 10.2741/1529. View

19.

Bresnick A, Weber D, Zimmer D . S100 proteins in cancer. Nat Rev Cancer. 2015; 15(2):96-109. PMC: 4369764. DOI: 10.1038/nrc3893. View

20.

Alajez N . Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence. PLoS One. 2016; 11(12):e0167455. PMC: 5147898. DOI: 10.1371/journal.pone.0167455. View